Additionally, immunomodulatory drugs (IMiDs) such as lenalidomide upregulates TRAIL expression on NK cells that potentially enhance the TRAIL-mediated elimination of tumor cells (14, 15). This evidence concerns the gene TNFSF10 and neoplasm.